Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 18 04:00PM ET
65.85
Dollar change
-0.46
Percentage change
-0.69
%
IndexNDX P/E34.50 EPS (ttm)1.91 Insider Own0.03% Shs Outstand3.10B Perf Week-2.69%
Market Cap204.16B Forward P/E14.24 EPS next Y4.62 Insider Trans0.00% Shs Float3.10B Perf Month4.79%
Income5.96B PEG2.70 EPS next Q0.97 Inst Own15.97% Short Float0.30% Perf Quarter-0.75%
Sales45.81B P/S4.46 EPS this Y12.38% Inst Trans-2.09% Short Ratio1.47 Perf Half Y-3.54%
Book/sh12.63 P/B5.22 EPS next Y13.32% ROA6.03% Short Interest9.26M Perf Year-0.20%
Cash/sh1.92 P/C34.24 EPS next 5Y12.80% ROE15.63% 52W Range60.47 - 76.56 Perf YTD-2.23%
Dividend Est.1.55 (2.35%) P/FCF22.02 EPS past 5Y17.72% ROI9.55% 52W High-13.99% Beta0.51
Dividend TTM1.45 (2.20%) Quick Ratio0.64 Sales past 5Y16.24% Gross Margin73.00% 52W Low8.90% ATR (14)1.03
Dividend Ex-DateFeb 22, 2024 Current Ratio0.82 EPS Y/Y TTM81.06% Oper. Margin16.21% RSI (14)50.10 Volatility1.21% 1.34%
Employees89900 Debt/Eq0.73 Sales Y/Y TTM3.29% Profit Margin13.00% Recom1.73 Target Price78.46
Option/ShortYes / Yes LT Debt/Eq0.59 EPS Q/Q6.03% Payout73.87% Rel Volume0.62 Prev Close66.31
Sales Surprise-0.46% EPS Surprise-0.85% Sales Q/Q7.29% EarningsFeb 08 BMO Avg Volume6.32M Price65.85
SMA200.21% SMA50-0.35% SMA200-2.05% Trades Volume3,886,403 Change-0.69%
Date Action Analyst Rating Change Price Target Change
Feb-08-24Downgrade Deutsche Bank Hold → Sell
Jan-23-24Initiated Morgan Stanley Overweight $85
Jan-16-24Resumed UBS Sell
Jan-03-24Downgrade Jefferies Buy → Hold $78.50 → $70
Dec-18-23Initiated HSBC Securities Buy $78
Sep-25-23Upgrade Jefferies Hold → Buy $66.50 → $80
Jul-14-23Initiated HSBC Securities Buy
Jul-12-23Upgrade UBS Neutral → Buy
Jul-05-23Downgrade Deutsche Bank Buy → Hold
Apr-11-23Upgrade Morgan Stanley Equal-Weight → Overweight
Mar-18-24 03:06PM
09:00AM
07:14AM
07:00AM
Mar-17-24 08:50AM
12:26PM Loading…
Mar-14-24 12:26PM
11:02AM
10:59AM
09:48AM
09:38AM
07:07AM
03:45AM
03:15AM
Mar-13-24 05:50PM
07:06AM
04:27AM Loading…
Mar-11-24 04:27AM
Mar-07-24 05:50PM
02:15PM
01:57PM
09:41AM
01:15AM
Mar-06-24 07:36PM
01:02PM
12:32PM
10:00AM
08:31AM
06:00AM
03:15AM
Mar-05-24 09:06AM
09:00AM
06:49AM Loading…
Mar-04-24 06:49AM
Mar-01-24 05:50PM
04:14PM
01:57PM
01:38PM
12:25PM
11:47AM
Feb-29-24 08:09AM
Feb-28-24 04:36AM
Feb-27-24 09:59AM
Feb-26-24 04:34PM
04:15PM
09:00AM
Feb-23-24 01:23PM
09:00AM
Feb-22-24 02:20AM
Feb-21-24 05:02AM
04:49AM
Feb-20-24 01:03PM
07:09AM
Feb-19-24 01:06PM
07:05AM
02:00AM
Feb-16-24 10:39PM
10:00PM
Feb-14-24 03:05PM
Feb-13-24 05:50AM
Feb-12-24 10:12PM
10:04PM
01:52PM
09:00AM
Feb-10-24 08:30AM
05:03AM
Feb-09-24 10:59AM
02:20AM
Feb-08-24 05:04PM
04:15PM
04:01PM
03:00PM
01:48PM
01:19PM
12:40PM
11:11AM
11:11AM
10:37AM
10:22AM
10:21AM
10:04AM
07:40AM
06:37AM
05:48AM
05:31AM
05:13AM
05:10AM
04:53AM
04:05AM
03:39AM
03:03AM
02:36AM
02:12AM
02:03AM
Feb-07-24 05:28PM
06:51AM
05:44AM
Feb-06-24 11:39PM
09:36AM
09:12AM
09:00AM
Feb-05-24 09:45PM
09:16AM
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.